📋 The Next 15 Costly Drugs Medicare Will Be Negotiating (AARP Article)

[Winter2025VA]

FROM THE ARTICLE: The list includes popular medications that treat diabetes, cancer, COPD, arthritis and IBS.

By Rachel Nania, AARP.

*** There are 94 Comments on AARP website. Stop by to add yours. ***

Published January 17, 2025.

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations for 10 drugs whose lower prices take effect in 2026. The newly selected medications are among the costliest for Medicare’s prescription drug program — accounting for about $41 billion in total Medicare Part D spending — and are used by about 5.3 million enrollees to treat common conditions such as cancer, diabetes and asthma.

Negotiations with drug manufacturers on this second round of medications will take place throughout 2025 and the new prices will take effect in 2027. The negotiated prices will be announced by Nov. 30, and soon after, Medicare will select additional medications for a third round of negotiations, with more to follow.

USE LINK BELOW TO READ ARTICLE: https://www.aarp.org/health/medicare-insurance/info-2025/more-medicare-drug-price-negotiations.html